Our results showed that A22 treatment significantly inhibited HF diet-induced macrophage aggregation, which were analyzed with specific antigen CD11b (for monocyte-derived macrophages) (Supplementary Figure S7A and C) and CD45 (for lymphocyte) (Supplementary Figure S7A and D). The gene discussed is PTPRC; the disease is hydrops fetalis.